We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Multidrug-Resistant Shigellosis Spreads Throughout the United States

By HospiMedica International staff writers
Posted on 21 Apr 2015
International travelers are bringing a multidrug-resistant intestinal illness called shigellosis to the USA and spreading it to others who have not traveled. More...


Shigella sonnei, the causative bacteria of the disease, have become resistant to the antibiotic ciprofloxacin which is the first choice to treat shigellosis among adults in the USA. Shigellosis can spread very quickly in groups like children in childcare facilities, homeless people, and gay and bisexual men, as occurred in several outbreaks.

Scientists at the Centers for Disease Control and Prevention (CDC; Atlanta, GA, USA) identified an increase in Shigella sonnei infections with an uncommon genetic fingerprint in December 2014. Further testing at CDC's National Antimicrobial Resistance Monitoring System (NARMS) laboratory found that the bacteria were resistant to ciprofloxacin (Cipro). The CDC’s PulseNet network detected several large clusters: 45 cases in Massachusetts; 25 cases in California; and 18 cases in Pennsylvania. About half of these cases with patient information were associated with international travel, mostly to the Dominican Republic and India. The San Francisco Department of Public Health (CA, USA) reported another 95 cases, with 9 of them among those identified by PulseNet, with almost half occurring among the homeless or people living in single-room occupancy hotels.

Shigella causes an estimated 500,000 cases of diarrhea in the USA every year. It spreads easily and rapidly from person to person and through contaminated food and recreational water. It can cause watery or bloody diarrhea, abdominal pain, fever, and malaise. Although diarrhea caused by Shigella typically goes away without treatment, people with mild illnesses are often treated with antibiotics to stop the diarrhea faster.

Until recently, Cipro resistance has occurred in just 2% of Shigella infections tested in the USA, but was found in 90% of samples tested in the recent clusters. The CDC recommends that health care providers should test stool samples from patients with symptoms consistent with shigellosis, re-test stool if patients do not improve after taking antibiotics, and test bacteria for antibiotic resistance.

Anna Bowen, MD, MPH, a medical officer at the CDC and lead author of the study said, “Shigella is already resistant to the antibiotics ampicillin and trimethoprim/sulfamethoxazole. Globally, Shigella resistance to Cipro is increasing. The increase in drug-resistant Shigella makes it even more critical to prevent shigellosis from spreading. Washing your hands with soap and water is important for everyone. Also, international travelers can protect themselves by choosing hot foods and drinking only from sealed containers.”

Related Links:

Centers for Disease Control and Prevention 
San Francisco Department of Public Health 



Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Pressure Guidewire
SavvyWire
Semi‑Automatic Defibrillator
Heart Save AED (ED300)
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The researchers grew pancreatic tissue (above) so it incorporated a mesh-like electronic network (red). Cells within the tissue produce insulin (green). (Photo courtesy of Penn Medicine)

‘Cyborg’ Transplants Could Replace Pancreatic Tissue Damaged by Diabetes

Type 1 diabetes destroys insulin-producing islet cells, forcing patients to rely on lifelong insulin therapy or scarce organ transplants. Although lab-grown pancreatic tissue offers a promising alternative,... Read more

Surgical Techniques

view channel
Image: The AI-based approach identifies lipid regions matched well with histopathology results (Photo courtesy of Hyeong Soo Nam/KAIST)

AI-Based OCT Image Analysis Identifies High-Risk Plaques in Coronary Arteries

Lipid-rich plaques inside coronary arteries are strongly associated with heart attacks and other major cardiac events. While optical coherence tomography (OCT) provides detailed images of vessel structure... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.